Expression of the 90K Tumor-Associated Protein in Benign and Malignant Melanocytic Lesions
- 1 July 2002
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 119 (1) , 187-190
- https://doi.org/10.1046/j.1523-1747.2002.17642.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Atypical spitz nevi/tumors: Lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcomePublished by Elsevier ,2004
- Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alphaGene Therapy, 2000
- Dimensionalities: Borderline and intermediate melanocytic neoplasiaHuman Pathology, 1999
- Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta 1 integrins, collagens and fibronectinThe EMBO Journal, 1998
- Molecular pathology of melanomaCancer and Metastasis Reviews, 1997
- 90K (Mac-2 BP) in human milkClinical and Experimental Immunology, 1996
- Beta1 integrin expression in malignant melanoma predicts occult lymph node metastasesSurgery, 1995
- The SRCR superfamily: a family reminiscent of the Ig superfamilyTrends in Biochemical Sciences, 1994
- The spectrum of minimal deviation melanoma: A clinicopathologic study of 21 casesHuman Pathology, 1986
- Minimal Deviation Melanoma: A Histologic Variant of Cutaneous Malignant Melanoma in Its Vertical Growth PhaseJournal of Investigative Dermatology, 1983